GB1522600A - Proteins - Google Patents

Proteins

Info

Publication number
GB1522600A
GB1522600A GB5188574A GB5188574A GB1522600A GB 1522600 A GB1522600 A GB 1522600A GB 5188574 A GB5188574 A GB 5188574A GB 5188574 A GB5188574 A GB 5188574A GB 1522600 A GB1522600 A GB 1522600A
Authority
GB
United Kingdom
Prior art keywords
water
soluble
plant material
separation
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5188574A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Original Assignee
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG, Boehringer Ingelheim GmbH filed Critical CH Boehringer Sohn AG and Co KG
Priority to GB5188574A priority Critical patent/GB1522600A/en
Publication of GB1522600A publication Critical patent/GB1522600A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

1522600 Plant protein purification BOEHRINGER INGELHEIM GmbH 1 Dec 1975 [29 Nov 1974] 51885/74 Heading C3H Water-soluble by-protein or mixture of byproteins in substantially pure form obtainable from the plant material of Canavalia ensiformis, Abeus praecatorius or Ricinus communis containing water-soluble agglutinins and/or toxins by separation of the latter component(s) from the water-soluble protein component(s) of the plant material are claimed per se. The plant material (preferably in the form of seeds) may be crushed, degreased and subjected to a first separation by means of extraction from NaCl solution and dialysing the water-insoluble toxic globulins. The remaining clean solution is further purified by salting out several times with a saturated (NH4)2SO4 solution. Final separation may be effected by electrophoresis, membrane diafiltration or chromatography.
GB5188574A 1975-12-01 1975-12-01 Proteins Expired GB1522600A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB5188574A GB1522600A (en) 1975-12-01 1975-12-01 Proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5188574A GB1522600A (en) 1975-12-01 1975-12-01 Proteins

Publications (1)

Publication Number Publication Date
GB1522600A true GB1522600A (en) 1978-08-23

Family

ID=10461783

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5188574A Expired GB1522600A (en) 1975-12-01 1975-12-01 Proteins

Country Status (1)

Country Link
GB (1) GB1522600A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414201A (en) 1979-11-09 1983-11-08 Eisai Co., Ltd. Immunopotentiator containing abrin
US4459287A (en) * 1979-11-09 1984-07-10 Eisai Co., Ltd. Immunopotentiator containing recin
EP0196762A1 (en) * 1985-03-29 1986-10-08 Cetus Corporation Recombinant ricin fragments, vectors and transformed hosts expressing the same, the modification of DNA sequences, and isolation of mRNA
US5840522A (en) * 1984-09-20 1998-11-24 Chiron Corporation Recombinant lectins
US6084073A (en) * 1985-03-25 2000-07-04 Chiron Corporation Recombinant ricin toxin

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414201A (en) 1979-11-09 1983-11-08 Eisai Co., Ltd. Immunopotentiator containing abrin
US4459287A (en) * 1979-11-09 1984-07-10 Eisai Co., Ltd. Immunopotentiator containing recin
US5840522A (en) * 1984-09-20 1998-11-24 Chiron Corporation Recombinant lectins
US6084073A (en) * 1985-03-25 2000-07-04 Chiron Corporation Recombinant ricin toxin
EP0196762A1 (en) * 1985-03-29 1986-10-08 Cetus Corporation Recombinant ricin fragments, vectors and transformed hosts expressing the same, the modification of DNA sequences, and isolation of mRNA

Similar Documents

Publication Publication Date Title
Maček et al. Isolation and characterization of three lethal and hemolytic toxins from the sea anemone Actinia equina L.
Palau et al. Histones from sperm of the sea urchin Arbacia lixula
Ferlan et al. Equinatoxin, a lethal protein from Actinia equina—I Purification and characterization
Csordas et al. Primary structure of two oligopeptides of the toxin of Bombina variegata L.
DK485287D0 (en) MEGAKARYOCYT STIMULATING FACTOR AND PROCEDURE FOR ISOLATING SUCH A FACTOR
DE3684078D1 (en) CLEANING AND ACTIVATION OF PROTEINS FROM INSOLUBLE INCLUDING BODIES.
EP0404202A3 (en) Agent for separating proteins from blood plasma
Lowy et al. On the erythropoietic principle in the blood of rabbits made severely anemic with phenylhydrazine
GB1522600A (en) Proteins
DE3230151A1 (en) NEW POLYPEPTIDE WITH EFFECT ON THE IMMUNE SYSTEM, METHOD FOR ITS INSULATION AND CLEANING, ITS USE, ITS CONTAINER, AND ITS DIFFERENT PRODUCTS, THEIR USE AND ITEMS
Seyer et al. The content and nature of the carbohydrate components of the organic matrix of embryonic bovine enamel
Ito et al. Studies on the Salivary Gland Hormones. XIV Isolation of Crystalline Parotin by Fractional Precipitation with Ammonium Sulfate
Ross Precipitin-reactions of human seminal plasma
ES437046A2 (en) Manufacture of novel amino acid derivative
Latner et al. Preparation of highly potent intrinsic factor mucoprotein
Moroz-Perlmutter et al. Biochemical and antigenic properties of a purified neurotoxin of Vipera palestinae venom
Daly et al. SYNTHESIS OF PROTEIN IN THE PANCREAS: III. UPTAKE OF GLYCINE-N15BY THE TRYPSINOGEN AND CHYMOTRYPSINOGEN OF MOUSE PANCREAS
JPS6490109A (en) Cosmetic
Fisher et al. Myoglobins of cartilaginous fishes III. Amino acid sequence of myoglobin of the shark Galeorhinus australis
US3475402A (en) Process of extracting proteins from mistle press juice by carrier-free electrophoresis
DE3166700D1 (en) A process for producing and obtaining anaphylatoxin- and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form
Yamazaki et al. Isolation and purification of colostrokinin from bovine colostrum
Wang Glycogen Production from Glucose with Desoxycorticosterone and 11-Dehydro-17-hydroxycorticosterone
Rangneker et al. A NOTE ON THE EFFECT OF GOLD AND VITAMIN C ON THE BLOOD LEVELS OF PHENYLALANINE AND TYROSINE IN RATS
Tewksbury et al. Preparation of human angiotensinogen for plasma renin concentration assay

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed